See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2018_AILERON_THERAPEUTICS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001420565')"} |
Graph
Absolute values for 0001420565, AILERON THERAPEUTICS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 51,840,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 154,000 |
| 3 | remainder_Assets | 694,000 |
| 4 | LiabilitiesCurrent | 4,891,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,769,000 |
| 9 | ResearchAndDevelopmentExpense | 14,239,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 404,000 |
| 13 | remainder_ComprehensiveNetIncome | -33,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 52,688,000 |
| 1 | Liabilities | 4,891,000 |
| 2 | Expenses | 23,008,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 47,797,000 |
| 5 | NetIncome | -22,604,000 |
| 6 | ComprehensiveNetIncome | -22,620,500 |
| 7 | BaseVar | 40,512,000 |
| 8 | EconomicCapitalRatio | 2.07 |